Notably, among the known genes we found the solute carrier family 2 member 1/glucose transporter 1 (SLC2A1/GLUT1) (Figure 2A), an important, stage independent predictor of ACC patient outcome [28] as well as those encoding for the sterol-O acyltransferase (SOAT1) (Figure 2B) and eukaryotic translation initiation factor 2 α (EIF2S1) (Figure 2C), both known to be involved in endoplasmic reticulum stress processes in the adrenocortical tissues associated with mitotane treatment and also having an influence on ACC patient outcome [29,30]. The gene discussed is SLC1A2; the disease is adrenal cortex carcinoma.